9885.HK

Pharmaceutical e-commerce platform YSB Inc. (9885.HK) announced on Thursday that it expects to record a net profit of 70 million yuan ($9.75 million) or more for the six months through June, more than triple the 21.8 million yuan it reported a year earlier.

The company credited the surge to steady revenue growth, strong demand for its high-margin self-branded products, and enhanced digital capabilities that improved the efficiency of its platform and direct-sales operations.

YSB‘s stock opened higher on Friday but later turn lower, closing at HK$10.02 by the midday break, down 2.34%. The stock is up 67.9% this year.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Futu does stocks

Is Futu’s bull run nearing an end?

The brokerage’s stock has more than doubled since the start of the year, as it records strong revenue and profit growth fueled by heavy trading volumes Key Takeaways: Futu reported…